Ags Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 4.50 M
- Paid Up Capital ₹ 4.50 M
- Company Age 11 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.90 Cr
- Satisfied Charges ₹ 1.76 Cr
- Revenue Growth 18.75%
- Profit Growth -13.75%
- Ebitda 10.13%
- Net Worth 6.80%
- Total Assets 8.23%
About Ags Pharmaceuticals
Ags Pharmaceuticals Private Limited (APPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 14 June 2013 and has a history of 11 years and seven months. Its registered office is in Thirupathur, Tamil Nadu, India.
The Corporate was formerly known as Ags Pharamaceuticals Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.50 M and a paid-up capital of Rs 4.50 M.
The company currently has active open charges totaling ₹5.90 Cr. The company has closed loans amounting to ₹1.76 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sujatha Sridharan and Sridharan Manivannan serve as directors at the Company.
Company Details
-
Location
Thirupathur, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24240TN2013PTC091683
-
Company No.
091683
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
14 Jun 2013
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Ags Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sujatha Sridharan
|
Director | 14-Jun-2013 | Current |
|
Sridharan Manivannan
|
Director | 30-Jun-2018 | Current |
Financial Performance of Ags Pharmaceuticals.
Ags Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 18.75% increase. The company also saw a substantial fall in profitability, with a 13.75% decrease in profit. The company's net worth moved up by a moderate rise of 6.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ags Pharmaceuticals?
In 2023, Ags Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹59.03 M
₹17.58 M
Charges Breakdown by Lending Institutions
- Others : 3.05 Cr
- Axis Bank Limited : 1.50 Cr
- Hdfc Bank Limited : 1.35 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jun 2024 | Others | ₹1.55 Cr | Open |
| 13 Jun 2023 | Axis Bank Limited | ₹1.50 Cr | Open |
| 27 Dec 2021 | Hdfc Bank Limited | ₹1.45 M | Open |
| 13 Oct 2021 | Hdfc Bank Limited | ₹1.21 Cr | Open |
| 11 Oct 2013 | Others | ₹1.50 Cr | Open |
How Many Employees Work at Ags Pharmaceuticals?
Unlock and access historical data on people associated with Ags Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ags Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ags Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
